In cooperation with


Endocrinologic aspects of anti-aging medicine

Normal aging is recognized increasingly as unhealthy and as an important cause for degenerative diseases in older adults. Efforts are taken to delay its onset and progression, well before the manifestation of clinical endpoints (preventive and anti-aging medicine). Scientificbased interventions include hormone replacement strategies, such as thyroxine (in hypothyreoidism), estrogen and progesterone (in menopause), testosterone (in andropause), and recently dehydroepiandrosterone (in adrenopause) and growth hormone (in somatopause) as well as some neurotransmitters. However, many of their aspects remain controversial, mostly due to insufficient study designs and have not been uniformly proven to be safe and of benefit in the long-term. New study data and low-risk basic application rules for some hormones are presented in the overview, which can support the decision making process.

CME Prakt Fortbild Gynakol Geburtsmed Gynakol Endokrinol 2015; 11(3): 208–226

Hormone replacement, estrogen, progesterone, testosterone, dehydroepiandrosterone (DHEA)

Alexander Römmler
Facharzt für Gynäkologie, Gyn-Endokrinologie, Prävention
und Anti-Aging-Medizin, München
Reviewer: Ludwig Wildt, Innsbruck,
und Andreas Lenhard, Bad Segeberg

Römmler A. Endokrinologische … Gynakol Geburtsmed Gynakol Endokrinol 2015; 11(3): 208–226 publiziert 30.11.2015 ©akademos Wissenschaftsverlag 2015 ISSN 1614-8533